Neuroblastoma detection using serum proteomic profiling: A novel mining technique for cancer?

Department of Surgery, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana, United States
Journal of Pediatric Surgery (Impact Factor: 1.39). 04/2006; 41(4):639-46; discussion 639-46. DOI: 10.1016/j.jpedsurg.2005.12.037
Source: PubMed


Serum proteins in neuroblastoma (NB), such as neuron-specific enolase and lactate dehydrogenase, are used as nonspecific markers of disease severity. In this study, we have generated serum protein profiles that correlate with NB by applying proteomic technologies to uncover, at the protein level, serum polypeptide expression patterns in patients with NB.
Surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry was used to generate protein expression spectra in human NB (group I, n = 18) and healthy children (group II, n = 17) sera. Groups I and II mass spectral data were compared after baseline subtraction. Peaks with high signal-to-noise ratios were selected and grouped into bins with various intervals along mass-to-charge axis. Two-sample t test and 3-fold cross validation were used to identify differential biomarkers between groups I and II.
Significant differentially expressed proteins were identified between groups I and II (P < or = .05). The discriminatory features (proteomic patterns) of cancer from normal sera were successfully identified using the classification algorithm. The average classification performance after 3-fold cross validation was 87.26%.
Surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry is suitable for preliminary assessment of NB and could potentially provide a noninvasive diagnosis of NB. We propose that surface-enhanced laser desorption/ionization provides a novel method for NB diagnosis because direct observations of spectral differences between normal and NB sera are possible.


Available from: Robert J Hickey
  • Source
    • "Biomarkers of high-grade NBs were investigated using an animal model and 2D-PAGE [109]. Plasma samples were compared between patients with NB and healthy donors by SELDI-ToF MS [106, 108], while conditioned media from NB cell lines were also examined by 2D-PAGE [107]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Soft tissue sarcomas are rare and account for less than 1% of all malignant cancers. Other than development of intensive therapies, the clinical outcome of patients with soft tissue sarcoma remains very poor, particularly when diagnosed at a late stage. Unique mutations have been associated with certain soft tissue sarcomas, but their etiologies remain unknown. The proteome is a functional translation of a genome, which directly regulates the malignant features of tumors. Thus, proteomics is a promising approach for investigating soft tissue sarcomas. Various proteomic approaches and clinical materials have been used to address clinical and biological issues, including biomarker development, molecular target identification, and study of disease mechanisms. Several cancer-associated proteins have been identified using conventional technologies such as 2D-PAGE, mass spectrometry, and array technology. The functional backgrounds of proteins identified were assessed extensively using in vitro experiments, thus supporting expression analysis. These observations demonstrate the applicability of proteomics to soft tissue sarcoma studies. However, the sample size in each study was insufficient to allow conclusive results. Given the low frequency of soft tissue sarcomas, multi-institutional collaborations are required to validate the results of proteomic approaches.
    06/2012; 2012(1):876401. DOI:10.1155/2012/876401
  • Source
    • "Enolase is a neuron-specific serum protein that has been used in previous studies to gauge the severity of neuroblastomas in humans (Sandoval et al., 2006). We observed three times the amount of enolase in BC 1 melanoma than in Sd-helleri F 1 fin tissue. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Interspecies hybridization between the platyfish X. maculatus Jp 163 A, and the swordtail X. helleri (Sarabia), generates F(1) hybrids with pronounced melanin pigmentation. Backcrossing of F(1) hybrids with the X. helleri parent results in 25% of progeny that will spontaneously develop melanoma. We have applied proteomic methods to this Gordon-Kosswig (G-K) melanoma model to identify candidate proteins that exhibit modulated expression in fin tissue due to interspecies hybridization and progression of hybrid tissues to spontaneous melanoma. Difference Gel Electrophoresis (DIGE) was used to minimize the variability commonly observed in quantitative analyses of comparative protein samples. Following identification of up- or down-regulated protein expression by DIGE, candidate protein spots were identified by mass spectrometric sequencing. Several protein expression differences displayed in interspecies hybrids were identified and compared to distinct differences that occur upon backcrossing and progression to melanoma. These studies are important for the identification of distinct biochemical pathways involved in the variety of Xiphophorus interspecies hybrid tumor models.
    Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology 06/2011; 155(1):81-8. DOI:10.1016/j.cbpc.2011.05.017 · 2.30 Impact Factor
  • Source
    Fang Li ·
    [Show abstract] [Hide abstract]
    ABSTRACT: A semi-automatic computer program GA/CA (genetic algorithm/correlation analysis) is developed in this project for the classification of chemical compounds using mass spectra. The program uses a genetic algorithm as the optimization method and correlation analysis as the evaluation method. In performing a classification, the GA/CA program searches for a group of mass peaks that best discriminate the substructure of interest using the mass spectra of known compounds, and then uses the search results on unknowns for prediction. The GA/CA program is able to perform the classification using mass spectra, neutral loss spectra and parent loss spectra, as well as perform data preprocessing techniques, such as intensity exponent scaling and thresholding. The GA/CA program is successfully used in two tests using library spectra: classification of lower aromatic compounds, and chlorine containing compounds. The chromosomes developed by the GA/CA program showed 100% prediction accuracy for the test compounds in both classification experiments. In the classification of carbamates, the best chromosomes developed by the GA/CA program result from use of the neutral loss spectra, which show a prediction accuracy of 93% on the test set. The prediction accuracy increased when the individual results obtained by use of mass spectra, neutral loss spectra and parent loss spectra are combined together. The GA/CA was also used for identification of the metabolites of the carbamate methyl thiophanate from LC-MS/MS data. Chromosomes were developed by the GA/CA program using spectra collected in the laboratory. The results showed that the GA/CA program identified three of the known metabolites correctly and one metabolite incorrectly. The GA/CA program also identified another possible metabolite that was not identified in a previous metabolic study. The GA/CA needs to be rewritten as a completely automatic program so that it can handle a larger number of spectral data and run for a large number of generations.
Show more